Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Keywords: Abstract
- Acute myocardial infarction
Emergency department treatment protocol for the patient with ST-seg-
- Acute coronary syndrome
ment-elevation acute coronary syndrome
- ST-elevation acute coronary
syndrome Acute coronary syndrome (ACS) is a major cause of mortality. It is essential to identify patients with ST-
- Primary angioplasty segment elevation (STSE ACS). These patients have an increased risk of complications and fast and
structured action in the emergency department is fundamental. The initial measures included checking
haemodynamic stability, performing an electrocardiogram, monitoring the patient, and ensuring the
availability of a defibrillator. STSE ACS is treated medically and by revascularisation. The initial objective
of medical treatment is symptom control and dual antiplatelet therapy with ASA and a P2Y 12 inhibitor,
preferably prasugrel or ticagrelor. There are two revascularisation techniques: primary angioplasty (of
choice if available in under 120 minutes) or fibrinolysis.
Dolor torácico
Diagnóstico de SCACEST
< 2 horas
Angioplastia primaria ¿Tiempo hasta angioplastia primaria?
> 2 horas
Fibrinólisis
tes, el anticoagulante de elección es enoxaparina, debiendo Confidencialidad de los datos. Los autores declaran que en
mantenerla hasta la revascularización, el alta hospitalaria o este artículo no aparecen datos de pacientes.
durante 8 días (lo que suceda antes)2,3.
Derecho a la privacidad y consentimiento informado. Los
autores declaran que en este artículo no aparecen datos de
pacientes.
Responsabilidades éticas
Protección de personas y animales. Los autores declaran Conflicto de intereses
que para esta investigación no se han realizado experimentos
en seres humanos ni en animales. Los autores declaran no tener ningún conflicto de intereses.
✔ Ensayo clínico controlado ✔ Guía de práctica clínica Gottlieb S, et al; TRITON-TIMI 38 Investigators. Prasugrel versus clo-
pidogrel in patients with acute coronary syndromes. N Engl J Med.
✔ Epidemiología ✔
6.
2007;357(20):2001-15.
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C,
et al; PLATO Investigators. Ticagrelor versus clopidogrel in patients with
✔1. • Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR.
Fourth universal definition of myocardial infarction (2018). Rev Esp 7.
acute coronary syndromes. N Engl J Med. 2009;361(11):1045-57.
Marzal Martín D, López-Sendón Henschel JL, Rodríguez Padial L. Pro-
Cardiol. 2019;72(1):72.e1-e27. ceso asistencial simplificado del síndrome coronario agudo. Madrid: So-
✔ ••
2. Ibáñez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, ciedad Española de Cardiología; 2016.
Bueno H, et al; ESC Scientific Document Group. 2017 ESC Guide-
lines for the management of acute myocardial infarction in patients
✔
8. • Keeley EC, Boura JA, Grines CL. Primary angioplasty versus in-
travenous thrombolytic therapy for acute myocardial infarction: a
presenting with ST-segment elevation: The Task Force for the ma- quantitative review of 23 randomised trials. Lancet. 2003;361(9351):
nagement of acute myocardial infarction in patients presenting with 13-20.
ST-segment elevation of the European Society of Cardiology (ESC).
Eur Heart J. 2018;39(2):119-77.
✔
9. Van de Werf F, Barron HV, Armstrong PW, Granger CB, Berioli S, Bar-
bash G, et al; ASSENT-2 Investigators, Assessment of the safety and effi-
✔ ••
3. O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung
MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the mana-
cacy of a new thrombolytic. Incidence and predictors of bleeding events
after fibrinolytic therapy with fibrin-specific agents: a comparison of
gement of ST-elevation myocardial infarction: a report of the Ame- TNK-tPA and rt-PA. Eur Heart J. 2001;22(24):2253-61.